JOHNSON & JOHNSON (JNJ)

US4781601046 - Common Stock

160.64  +1 (+0.63%)

After market: 160.9 +0.26 (+0.16%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

JOHNSON & JOHNSON

NYSE:JNJ (7/26/2024, 7:04:00 PM)

After market: 160.9 +0.26 (+0.16%)

160.64

+1 (+0.63%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS SubIndustry
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%
Sales Q2Q%
CRS
6 Month0.71%
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap386.61B
Shares
PE15.33
Fwd PE14.57
Dividend Yield3.17%
Analysts
IPO
Stock Screener Links
Screen Image

New York Stock Exchange, Inc. Stock Screener

Find more stocks on New York Stock Exchange, Inc.

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

JNJ Daily chart

Company Profile

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. The company is headquartered in New Brunswick, New Jersey and currently employs 131,900 full-time employees. The firm's primary focus is products related to human health and well-being. The company operates through two segments: Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. Products in this segment are distributed directly to retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment includes a broad portfolio of products used in the orthopedic, surgery, interventional solutions, cardiovascular intervention, and vision fields. The MedTech segment also offers a commercially available intravascular lithotripsy (IVL) platform for coronary artery disease (CAD) and peripheral artery disease (PAD).

Company Info

JOHNSON & JOHNSON

One Johnson & Johnson Plaza

New Brunswick NEW JERSEY 08933

P: 17325242455

CEO: A. Gorsky

Employees: 131900

Website: https://www.jnj.com/

JNJ News

News Image12 hours ago - Beasley Allen Law FirmCourts, Congress Likely to Stand in Way of J&J’s Third Texas Two-Step Plan
News Image12 hours ago - Ad Hoc Group of CounselFINAL DEADLINE: Ovarian Cancer Victims Have Until 5pm ET Today to Vote on Approximately $8 Billion J&J Talc Compensation Plan
News Imagea day ago - BloombergJ&J Loses Latest Legal Bid to Revive Talc Bankruptcy Strategy

Johnson & Johnson lost its bid in a federal appeals court to revive a plan to settle tens of thousands of talc cancer lawsuits by placing a subsidiary into bankruptcy.

News Imagea day ago - InvestorPlace3 Stocks Reeling From Ruined Reputations: Can They Recover?

Unforced errors by each of these controversial stocks has sullied their reputations and recovering them will not be easy or cheap.

News Imagea day ago - Market News VideoNoteworthy Thursday Option Activity: JNJ, PAYC, TGT
News Imagea day ago - Market News VideoJNJ September 6th Options Begin Trading

JNJ Twits

Here you can normally see the latest stock twits on JNJ, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example